Becton Dickinson & Co. header image

Becton Dickinson & Co.

BDX

Equity

ISIN null / Valor 912061

New York Stock Exchange, Inc (2026-10-08)
USD 182.75+1.44%

Becton Dickinson & Co.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Becton Dickinson & Co. (BD) is a long-established, publicly traded medical technology company headquartered in Franklin Lakes, New Jersey, that designs, manufactures and sells a broad range of medical devices, instrument systems and diagnostic products for healthcare institutions, clinical laboratories, life sciences researchers and pharmaceutical manufacturers. Its offerings include needles and syringes, infusion and medication-delivery systems, catheter and vascular access devices, prefillable drug-delivery systems and related pharmaceutical manufacturing services, as well as diagnostic instruments, specimen collection and preanalytical systems and reagents used in clinical and molecular diagnostics. BD operates globally across multiple business units that serve hospitals, outpatient facilities, labs and biopharma customers, combining product sales with service and technical support for clinical and research workflows.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-5.76%1Y
-30.4%3Y
-23.4%5Y

Performance

31.7%1Y
28.2%3Y
25.7%5Y

Volatility

Market cap

49779 M

Market cap (USD)

Daily traded volume (Shares)

1,523,705

Daily traded volume (Shares)

1 day high/low

227.8 / 225.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
17.46%USD 119.47
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%USD 105.96
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.01%USD 28.06
Harrow Inc
Harrow Inc Harrow Inc Valor: 45675535
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.33%USD 30.52
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.37%USD 387.12
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.50%USD 16.37
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 7.96
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.08%USD 34.83
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.35%USD 188.12
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%USD 36.16